CoChat

Combination Lipid Therapy in Type 2 Diabetes

Christoph H Saely, Philipp Rein, Heinz Drexel · 2010 · New England Journal of Medicine

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmc1006407

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 12 references

Research works printed but not linked: 2

  1. 10.1001/jama.2009.1619 · DOI · Paper page
  2. 10.1056/NEJMoa1001282 · DOI · Paper page

Cited by

See all 245

Metadata

Authors
Saely, C. H., Rein, P., & Drexel, H.
Venue
New England Journal of Medicine
Published
2010-08-12
Volume
363
Issue
7
Pages
692-695
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1519335354
Cited by
245
References
12
Citations by year
2026: 2 · 2025: 6 · 2024: 9 · 2023: 12 · 2022: 10 · 2021: 6 · 2020: 17 · 2019: 19 · 2018: 17 · 2017: 23 · 2016: 28 · 2015: 20 · 2014: 14 · 2013: 21 · 2012: 17
FWCI
20.43
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
type 2 diabetes, lipid-lowering therapy, hypertriglyceridemia, dyslipidemia, cardiovascular risk
MeSH terms
Hypolipidemic Agents, Coronary Artery Disease, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Humans, Cholesterol, HDL, Male, Fenofibrate, Risk, Triglycerides, Hypertriglyceridemia, Proportional Hazards Models, Simvastatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination Lipid Therapy in Type 2 Diabetes. https://app.cochat.ai/papers/10.1056/nejmc1006407
The paper
Saely, C. H., Rein, P., & Drexel, H. (2010). Combination Lipid Therapy in Type 2 Diabetes. New England Journal of Medicine. https://doi.org/10.1056/nejmc1006407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.